← Open Payments lookup

SAENGDAO PHONXAYLINKHAM: Open Payments

NPI 1083253975 · MADERA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$2,117 in 17 payments from 14 companies in 2025. Trend: 2023 $1,689 · 2024 $2,696 · 2025 $2,117

Food & beverage: $2,117
CompanyPaymentsAmount
Alnylam Pharmaceuticals Inc.2$283
Novo Nordisk Inc2$250
ABBVIE INC.2$250
Madrigal Pharmaceuticals1$147
Kowa Pharmaceuticals America, Inc.1$125
Eisai Inc.1$125
ARGENX US, INC.1$125
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$123
Exact Sciences Corporation1$122
Dexcom, Inc.1$122

Products named: ONPATTRO, REZDIFFRA, ZORYVE, Leqembi, Wegovy, VRAYLAR, VYVGART, Ozempic.

Industry payments across CA — which companies pay providers there.